DrDre' said:
I have always wondered if anyone has actually studied or tested whether LR would cause coagulation with blood or not. I tend to think it is theoretical but have been too lazy to look it up.
The only resultd I have found regarding this:
Edwards MP; Clark DJ; Mark JS; Wyld PJ: Compound sodium lactate (Hartmann's) solution. Caution: risk of clotting. Anaesthesia
1986 Oct; Vol. 41 (10), pp. 1053-4.
Abstract: We have observed blood clotting in blood administration sets where Hartmann's solution (Travenol) has preceded blood transfusion.
This is due to calcium ions (Ca++) contained in the Hartmann's solution and is more likely to occur at 37 degrees C. We suggest that this potential hazard be more widely realised and that the practice cease.
=============================
Lorenzo M; Davis JW; Negin S; Kaups K; Parks S; Brubaker D; Tyroch A: Can Ringer's lactate be used safely with blood transfusions? Am J Surg]
1998 Apr; Vol. 175 (4), pp. 308-10
BACKGROUND: Blood bank recommendations specify that Ringer's lactate solution (LR) should be avoided while transfusing blood. However, there are few studies either evaluating or quantifying increased coagulation during rapid infusion of LR and blood. DESIGN AND METHODS: Whole blood (WB, n = 25) and packed red blood cells (PRBC, n = 26) were rapidly admixed with normal saline (NS), Lactate solution and LR with 1 g (LR-1), 2 g (LR-2), and 5 g (LR-5) CaCl2/L solutions for assessment of infusion time, filter weight, and clot formation. RESULTS:
No significant differences in infusion time or filter weight using WB or PRBC with NS or LR were seen. No significant difference in clot formation between NS and LR with WB or PRBC was found, but the presence of visible clot was increased in the LR-5 group (P = 0.013, WB, and P = 0.002, PRBC). CONCLUSION: A comparison of LR and NS with rapid infusion rates of blood showed no significant difference between infusion time, filter weight and clot formation.
Blood bank guidelines should be revised to allow the use of LR in the rapid transfusion of PRBC.
================
Ryden SE; Oberman HA: Compatibility of common intravenous solutions with CPD blood. Transfusion
1975 May-Jun; Vol. 15 (3), pp. 250-5.
Blood anticoagulated with CPD was mixed with lactated Ringer's solution, 5 per cent aqueous dextrose, 5 per cent dextrose in 0.225 per cent saline, 5 per cent dextrose in 0.9 per cent saline, and 0.9 per cent saline solution in varying concentrations and incubated at room temperature and 37 C. Clots formed in the blood-lactated Ringer's mixture after five minutes at a citrate:calcium molar ratio of 4:1 or lower. Aqueous dextrose-blood mixtures showed immediate clumping with gross hemolysis after 30 minutes incubation. Blood mixed with 5 per cent dextrose and 0.225 per cent saline hemolyzed within ten minutes incubation at 37 C. No hemolysis occurred in blood mixed with 5 per cent dextrose in 0.9 per cent saline or with 0.9 per cent saline. Traces of solutions labeled with Evans blue dye remained in intravenous administration tubing even 30 minutes after a simulated transfusion was begun. Lactated Ringer's solution and 5 per cent dextrose in 0.225 per cent saline should not be administered concurrently with blood. Lactated Ringer's solution may also be harmful when used to start transfusions as it rapidly produces clots when mixed with CPD blood.
==================================